When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...